Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label zebrafish. Show all posts
Showing posts with label zebrafish. Show all posts

Thursday, January 29, 2026

Protective Effect of Cordyceps militaris Extract Against Cigarette Smoke Extract Induced Neurodegeneration in Zebrafish Model

My knowledge of cordyceps is my trip to Bhutan, nothing specific, so no recommendations there.

The Effects of Cordyceps in Ischemic Stroke: A Systematic Review of Animal Studies April 2025

Protective Effect of Cordyceps militaris Extract Against Cigarette Smoke Extract Induced Neurodegeneration in Zebrafish Model

    Abstract

    Background and Objectives: 

    Neurodegenerative diseases are characterized by degeneration or progressive loss/death of neurons in specific areas of the brain, often worsened by cigarette smoke through oxidative stress and inflammation. Cordyceps militaris (C. militaris) exhibits antioxidant and anti-inflammatory properties, suggesting potential neuroprotective effects. This study evaluated the protective role of C. militaris hot water extract (CMWE) against cigarette smoke extract-induced neurodegeneration in zebrafish. 

    Methods: 

    Neurodegeneration was induced in zebrafish using cigarette smoke extract, and CMWE was administered at 1 mg/L and 4 mg/L. Behavioral performance was assessed using Y-maze, inhibitory avoidance, and novel tank tests. LC-MS was employed to identify CMWE constituents, while antioxidant activity was evaluated by the DPPH assay. Histological analysis of the periventricular grey zone (PGZ) of the optic tectum was performed to assess neuronal integrity. 

    Results: 

    Cigarette smoke exposure led to aimless exploration, impaired memory retention, and increased bottom-dwelling behavior. CMWE improved behavioral outcomes, with 4 mg/L showing greater efficacy than 1 mg/L. LC-MS revealed bioactive compounds including cordycepin, adenosine, ergothioneine, D-mannitol, and vitamins. The DPPH assay confirmed strong antioxidant activity. Histological evaluation showed reduced pyknotic neuronal density in CMWE-treated groups compared with diseased controls, indicating anti-inflammatory effects. 

    Conclusions: 

    CMWE mitigated cigarette smoke-induced behavioral and histological hallmarks of neurodegeneration in zebrafish, likely via synergistic antioxidant and anti-inflammatory mechanisms. These findings support the potential of C. militaris as a natural product-based therapeutic candidate for neurodegenerative disorders, warranting further studies on its individual constituents and mechanisms of action.

     This is a preview of subscription content, log in via an institution  to check access.

    Monday, January 26, 2026

    Nanoscale magnesium hydride alleviates hypoxia-induced myelination deficits in zebrafish

     Can't our fucking failures of stroke associations and stroke medical 'professionals' look at this and see that further research is needed for our myelin damage

    Nanoscale magnesium hydride alleviates hypoxia-induced myelination deficits in zebrafish


    Li, Jia-Lin1,2,#; Chen, Qiang1,#; Li, Zheng-Hao1,#; Xu, Dao-Jie3He, Cheng1,*Liu, Peng1,*

    Author Information
    Medical Gas Research ():10.4103/mgr.MEDGASRES-D-25-00104, January 23, 2026. | DOI: 10.4103/mgr.MEDGASRES-D-25-00104
    • Open
    • PAP

    Abstract

    figure1

    Defects in myelination impair nerve impulse conduction and functional connectivity, which could lead to cognitive, behavioral and motor deficits in various neurological disorders. Adequate oxygen delivery is vital for brain development, while hypoxia in newborns tends to result in developmental deficiencies in myelination of the brain. The disruption of oligodendrocytes and their progenitor cells caused by hypoxia has been well researched. Nonetheless, the impairing dynamic myelination process is still unclear. Utilizing zebrafish as a model, we established hypoxia via cobalt chloride exposure or low oxygen (8%) incubation. Hypoxia significantly reduced oligodendrocyte progenitor cell numbers in the dorsal spinal cord, impaired migration velocity and suppressed proliferation. Myelination deficits were evident through decreased myelin sheath segment intensity in Tg(MBP:eGFP-CAAX) larvae. Time-lapse imaging revealed compromised dynamic myelination by individual oligodendrocytes under hypoxia, with fewer sheaths and reduced extension rates. Mechanistically, hypoxia elevated reactive oxygen species levels and disrupted mitochondrial membrane potential in cultured rat oligodendrocyte progenitor cells. Nanoscale magnesium hydride, a hydrogen-releasing agent, attenuated these effects. In vivo, magnesium hydride treatment rescued oligodendrocyte progenitor cell numbers and enhanced myelinogenesis capacity in hypoxic zebrafish. These findings demonstrate that magnesium hydride mitigates hypoxia-induced oxidative stress and mitochondrial dysfunction, thereby alleviating myelination deficits.

    Friday, August 29, 2025

    Stem Cells Use Toggle Switch to Regenerate Neurons

     Do you really think your competent doctor and hospital will ensure human testing gets going along with other areas of the brain? I don't think you have a competent doctor or hospital! Prove me wrong.

    Do you prefer your doctor and hospital incompetence NOT KNOWING? OR NOT DOING?

    Stem Cells Use Toggle Switch to Regenerate Neurons

    Summary: Scientists have uncovered how stem cells in the olfactory system continually regenerate neurons responsible for our sense of smell. Using live zebrafish imaging, cell tracking, and single-cell RNA sequencing, researchers identified a bistable toggle switch that drives progenitor cells to commit to specific fates and self-organize into “cellular neighborhoods.”

    These findings explain how fluctuating, noisy signals can reliably produce new neurons throughout life. The work opens the door to applying these mechanisms in broader contexts, potentially advancing treatments for neurodevelopmental and neurodegenerative diseases.

    Key Facts

    • Toggle Switch: A bistable signaling mechanism controls stem cell fate in the olfactory system.
    • Sustained Regeneration: Human olfactory neurons regenerate every few months across the lifespan.
    • Therapeutic Potential: Findings may guide future approaches for brain repair and neurodegenerative disease treatments.

    Source: University of Alabama Birmingham

    Cellular differentiation of stem cells into specialized cells requires many steps, including division, to create more cells; fate determination, which is a commitment to a specific lineage or developmental path; and migration, to integrate the cell into its final location.

    Previous in vitro work has shown that stem cells can spontaneously self-organize into groups of specialized cell types, yet little is known about how that happens in living animals — where densely populated microenvironments have high degrees of noise in cell-to-cell signaling and variations in gene expression.

    This shows neurons.
    n doing so, they showed how signaling that guides continuous neural development is integrated at multiple scales — single cells, small clusters of cells and between entire organs. Credit: Neuroscience News

    In their study and a featured cover image in a special issue of Stem Cell Reports on Neural Stem Cells, researchers at the University of Alabama at Birmingham and the University of Illinois Chicago describe signaling mechanisms that determine one such example of vertebrate development — the transition from olfactory stem cells into highly regenerative olfactory neurons that are responsible for the sense of smell.

    Applying multiple techniques including high-resolution imaging of live zebrafish embryos, quantitative tracking of cell fate and single-cell RNA sequencing, researchers identified a unique bistable toggle switch that assigns divergent cell fates to progenitor cells and drives their assembly into cellular “neighborhoods.”

    In doing so, they showed how signaling that guides continuous neural development is integrated at multiple scales — single cells, small clusters of cells and between entire organs.

    The study describes “a previously unknown paradigm of cellular neighborhood assembly through which the olfactory epithelium integrates fluctuating, stochastic signals to streamline fate commitment, differentiation and integration into the olfactory neuronal rosette,” wrote lead author Sriivatsan Govinda Rajan, Ph.D., and corresponding author Ankur Saxena, Ph.D., UAB Department of Cell, Developmental and Integrative Biology.

    “These findings reveal how stochastic signaling networks spatiotemporally regulate a balance between progenitors and derivatives, driving sustained neurogenesis in an intricate organ system.”

    “Remarkably, the human nose turns over its neurons every couple of months or so throughout our lifetimes,” Saxena said.

    “Given this unusual neuroregeneration, we wanted to answer a fundamental question: How do stem cells funnel fluctuating signals to make new neurons over and over again?

    “Now, we’re building on our molecular ‘answers’ from the zebrafish model system by asking if the identified molecular pathways can be applied in other contexts to shape the nervous system across vertebrates.

    “Long-term, our hope is to discover new therapeutic avenues for patients with neurodevelopmental or neurodegenerative disorders.”

    Co-authors with Rajan and Saxena in the study, “Progenitor neighborhoods function as transient niches to sustain olfactory neurogenesis,” are Lynne M. Nacke, UAB Department of Cell, Developmental and Integrative Biology; and Joseph N. Lombardo, Farid Manuchehrfar, Kaelan Wong, Pinal Kanabar, Elizabeth A. Somodji, Jocelyn Garcia, Mark Maienschein-Cline and Jie Liang, University of Illinois Chicago.

    At UAB, Cell, Developmental and Integrative Biology is a department in the Marnix E. Heersink School of Medicine.

    More information about the Saxena Lab’s work can be found at www.saxenalab.com. Rajan is now at Memorial Sloan Kettering Cancer Center, New York City, New York.

    About this genetics and neuroregeneration research news

    Author: Jeffrey Hansen
    Source: University of Alabama at Birmingham
    Contact: Jeffrey Hansen – University of Alabama at Birmingham
    Image: The image is credited to Neuroscience News

    Original Research: Open access.
    Progenitor neighborhoods function as transient niches to sustain olfactory neurogenesis” by Sriivatsan Govinda Rajan et al. Stem Cell Reports


    Saturday, December 18, 2021

    Parp1 promotes sleep, which enhances DNA repair in neurons

    What is your doctor's sleep protocol? Mine seemed to be, hand out sleeping pills like candy at 10pm, then have the vampire squad come in at 7am to steal blood from at least one person in the quad. Turning on the lights in the process, clinical staff efficiency, not patient wellbeing. 

    Hope your doctors and hospital can get research initiated in humans.

    Parp1 promotes sleep, which enhances DNA repair in neurons

     

    https://doi.org/10.1016/j.molcel.2021.10.026Get rights and content
    Referred to by
    Ueli Schibler
    PARP-1 drives slumber: A reciprocal relationship between sleep homeostasis and DNA damage repair
    Molecular Cell, Volume 81, Issue 24, 16 December 2021, Pages 4958-4959

    Highlights

    Neuronal DNA damage triggers sleep

    Sleep increases DNA repair and reduces cellular homeostatic pressure

    Activity of the DNA damage detector Parp1 increases with sleep deprivation

    Parp1 activity promotes sleep, chromosome dynamics, and DNA repair

    Summary

    The characteristics of the sleep drivers and the mechanisms through which sleep relieves the cellular homeostatic pressure are unclear. In flies, zebrafish, mice, and humans, DNA damage levels increase during wakefulness and decrease during sleep. Here, we show that 6 h of consolidated sleep is sufficient to reduce DNA damage in the zebrafish dorsal pallium. Induction of DNA damage by neuronal activity and mutagens triggered sleep and DNA repair. The activity of the DNA damage response (DDR) proteins Rad52 and Ku80 increased during sleep, and chromosome dynamics enhanced Rad52 activity. The activity of the DDR initiator poly(ADP-ribose) polymerase 1 (Parp1) increased following sleep deprivation. In both larva zebrafish and adult mice, Parp1 promoted sleep. Inhibition of Parp1 activity reduced sleep-dependent chromosome dynamics and repair. These results demonstrate that DNA damage is a homeostatic driver for sleep, and Parp1 pathways can sense this cellular pressure and facilitate sleep and repair activity.

    Monday, April 26, 2021

    Neuroprotective Effect of Tephrosia purpurea Against Mitochondrial Dysfunction by Regulation of the Caspase3/9 and Pink1/Parkin Complexes

    Lots of work for your doctor and stroke hospital to initiate. You don't want to get Parkinsons and this will eventually need to get to human testing. So if your hospital starts RIGHT NOW, in 15 years we might have results. So probably not in time for you but maybe in time for your children and grandchildren. 

    Parkinson’s Disease May Have Link to Stroke March 2017 

    HAS YOUR HOSPITAL DONE ONE DAMN THING IN THE PAST FOUR YEARS TO CREATE PROTOCOLS THAT PREVENT PARKINSONS? 

    Or are you giving them a pass to be incompetent with no consequences except to you?

    The latest here: 

     Neuroprotective Effect of Tephrosia purpurea Against Mitochondrial Dysfunction by Regulation of the Caspase3/9 and Pink1/Parkin Complexes

    Abstract 

    Background: 
    Tephrosia pupurea is a perennial shrub that has been widely incorporated in Indian traditional medicine for its anti-inflammatory and hepatoprotective effects. Recent studies have identified T. purpurea as a source of acetylcholine esterase inhibitors. 
    Aim: 
    In this study, we have established the potential of T. purpurea as a potential source of drugs against Parkinsonism using an oxidopamine (6-OHDA) model. Methods: Metabolomics profiling of T. purpurea extract (TPE) was obtained using the HR-LCMS method. Enzymatic activities of Catalase, Glutathione, Superoxide Dismutase and Malondialdehyde were measured in vitro. Reactive Oxygen Species generation capacity and the mitochondrial membrane potential were also determined. The zebrafish embryos were treated with oxidopamine along with varying concentrations of T. purpurea extract and the swimming pattern and total distance travelled was evaluated. The mRNA expression of mitophagy related genes were measured using RT-PCR studies.  
    Results: 
    The metabolite profile of T. purpurea identified the presence of various polyphenols such as Genistein, Esculetin, and Chrysin that have neuroprotective effects. 6-OHDA-induced PD causes an increase in oxidative stress, reactive oxygen species generation, and affects mitochondrial stability. There was a significant increase in the catalase, glutathione, and superoxide dismutase levels and a decrease in Malondialdehyde and Reactive Oxygen Species levels in cells treated with TPE when compared to 6-OHDA treated cells. We then treated zebrafish embryos with 6-OHDA along with varying concentrations of T. purpurea extract, and the mRNA expression and swimming pattern were evaluated. The embryos cotreated with TPE showed improved swim pattern similar to untreated embryos, whereas those treated with the positive control failed to do so. T. purpurea extract also significantly decreased the expressions of casp3, casp9, lrrk2, and increased pink1 and parkin expression. 
    Conclusion: 
    Our study identifies Tephrosia purpurea extract as a viable candidate against 6-OHDA induced-neurotoxicity, and further studies of its effect in models of neurodegenerative diseases are required. Keywords: Caspases, oxidopamine, Pink1/Parkin, Tephrosia purpurea, zebrafish How to cite this article: Kesh S, Kannan RR. Neuroprotective Effect of Tephrosia purpurea Against Mitochondrial Dysfunction by Regulation of the Caspase3/9 and Pink1/Parkin Complexes. Int J Nutr Pharmacol Neurol Dis 2021;11:137-47 How to cite this URL: Kesh S, Kannan RR. Neuroprotective Effect of Tephrosia purpurea Against Mitochondrial Dysfunction by Regulation of the Caspase3/9 and Pink1/Parkin Complexes. Int J Nutr Pharmacol Neurol Dis [serial online] 2021 [cited 2021 Apr 26];11:137-47. Available from: https://www.ijnpnd.com/text.asp?2021/11/2/137/314375 

    Tuesday, October 10, 2017

    Injectable Functionalized Self-assembling Nanopeptide Hydrogel on Angiogenesis and Neurogenesis for Central Nervous System Regeneration

    Ok, WHOM is going to follow this up in humans? Zebrafish are ok but we need to get to primates. 

    Injectable Functionalized Self-assembling Nanopeptide Hydrogel on Angiogenesis and Neurogenesis for Central Nervous System Regeneration   


    Could we do nasal route instead of injections?

    Abstract

    Brain injury is a devastating medical condition and represents a major health problem. For such disease, tissue and organ reconstruction has been regarded as a promising therapeutic strategy. Here, we propose a regenerative methodology focusing on the provision of functionalized nanopeptide scaffold to facilitate angiogenesis and neurogenesis at the brain injury site. The peptide, RADA16-SVVYGLR, undergoes self-assembling process to construct an interconnected network with intertwining nanofibers and can be controlled to display various physicochemical properties by the adjustment of microenvironmental factors such as pH value and ions concentration. Such scaffold is capable of supporting endothelial cells to form tube-like structure and neural stem cells to survive and proliferate. In in vivo zebrafish brain injury model, sprouting angiogenesis and developmental neurogenesis are achieved, and functional recovery of severed optic tectum is effectively enhanced in RADA16-SVVYGLR hydrogel-implanted group. Meanwhile, the nanopeptide hydrogel is non-toxic to zebrafish embryo during embryonic developmental stage. The angiogenic self-assembling peptide hydrogel has programmable physical properties, good biocompatibility, and regenerative ability for functional recovery in the injured brain. We suggest that functionalized self-assembling peptide encapsulated with neural stem cells or used alone could be an attractive and effective therapeutic modality for the applications in brain injury and diseases (viz., trauma, stroke, tumor, degenerative neurological disorder, etc).

    Monday, May 8, 2017

    Newly discovered scavenger brain cells could protect against stroke and dementia

    Followup needed, but we have fucking failures of stroke associations that will do nothing with this information.
    http://www.fiercebiotech.com/research/newly-discovered-scavenger-brain-cells-could-protect-against-stroke-and-dementia
    by Arlene Weintraub |
    Lymphatic cells are the body’s garbage-disposal system: When fats and other waste products leak out of blood vessels, they mop them up so they don’t damage organs. These types of cells have not been seen in the brain, however, so scientists at the University of Queensland in Australia were surprised when they found a new type of lymphlike cell there.
    By studying transparent zebrafish, the scientists observed scavenger cells surrounding the brain that clear out cellular waste. The cells are similar to "mato," or lipid-laden, cells in people, which were not previously known to be lymphatic, according to a press release. Ben Hogan, Ph.D., an associate professor in the university’s Institute for Molecular Bioscience, believes similar cells may be active in the human brain as well, protecting it against stroke and dementia by keeping harmful substances out.
    Normally, lymphatic cells clump together, forming vessel-like structures that carry fluid, Hogan explained. But in zebrafish brains, “these cells exist individually, independent of vessels and collect waste that enter the brain from the bloodstream,” he said in the release.
    Because zebrafish have many of the same cells and organs as people do, the discovery could enhance the study of brain disorders and treatments, Hogan added. The study was published in the journal Nature Neuroscience.
    Zebrafish are being deployed in research for a range of diseases, from cancer to diabetes. Last year, scientists at Boston Children’s Hospital used the transparent creatures to visualize the spread of melanoma from a single cell, and in so doing identified genes involved in metastasis that they believe could be targets for new treatments. Researchers at the University of Oregon found a protein in zebrafish that seems to boost insulin production. And a team at Johns Hopkins has developed genetically modified zebrafish embryos that can be used in high-throughput screening for potential new drugs.
    The University of Queensland team plans to expand upon their findings by studying how the cells they discovered function in people and how they influence neurological diseases such as stroke and dementia. They are also interested in learning whether existing drugs can directly control the scavenger cells in the brain, Hogan said.

    Sunday, January 6, 2013

    Brain endogenous liver X receptor ligands selectively promote midbrain neurogenesis

    I liked the words neurogenesis and liver in the same title.
    http://www.nature.com/nchembio/journal/vaop/ncurrent/full/nchembio.1156.html

    Abstract

    Liver X receptors (Lxrα and Lxrβ) are ligand-dependent nuclear receptors critical for ventral midbrain neurogenesis in vivo. However, no endogenous midbrain Lxr ligand has so far been identified. Here we used LC/MS and functional assays to identify cholic acid as a new Lxr ligand. Moreover, 24(S),25-epoxycholesterol (24,25-EC) was found to be the most potent and abundant Lxr ligand in the developing mouse midbrain. Both Lxr ligands promoted neural development in an Lxr-dependent manner in zebrafish in vivo. Notably, each ligand selectively regulated the development of distinct midbrain neuronal populations. Whereas cholic acid increased survival and neurogenesis of Brn3a-positive red nucleus neurons, 24,25-EC promoted dopaminergic neurogenesis. These results identify an entirely new class of highly selective and cell type–specific regulators of neurogenesis and neuronal survival. Moreover, 24,25-EC promoted dopaminergic differentiation of embryonic stem cells, suggesting that Lxr ligands may thus contribute to the development of cell replacement and regenerative therapies for Parkinson's disease.

    Wednesday, December 19, 2012

    Ve-ptp Modulates Vascular Integrity by Promoting Adherens Junction Maturation

    You doctor and researcher needs to inform you if this condition is a problem for you as a bleeder stroke. And what they are doing to correct it.
    http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0051245

    Abstract

    Background

    Endothelial cell junctions control blood vessel permeability. Altered permeability can be associated with vascular fragility that leads to vessel weakness and haemorrhage formation. In vivo studies on the function of genes involved in the maintenance of vascular integrity are essential to better understand the molecular basis of diseases linked to permeability defects. Ve-ptp (Vascular Endothelial-Protein Tyrosine Phosphatase) is a transmembrane protein present at endothelial adherens junctions (AJs).

    Methodology/Principal Findings

    We investigated the role of Ve-ptp in AJ maturation/stability and in the modulation of endothelial permeability using zebrafish (Danio rerio). Whole-mount in situ hybridizations revealed zve-ptp expression exclusively in the developing vascular system. Generation of altered zve-ptp transcripts, induced separately by two different splicing morpholinos, resulted in permeability defects closely linked to vascular wall fragility. The ultrastructural analysis revealed a statistically significant reduction of junction complexes and the presence of immature AJs in zve-ptp morphants but not in control embryos.

    Conclusions/Significance

    Here we show the first in vivo evidence of a potentially critical role played by Ve-ptp in AJ maturation, an important event for permeability modulation and for the development of a functional vascular system.

    Tuesday, December 11, 2012

    Inflammation to Rebuild a Brain

    You'll have to have your doctor to get the full article and apply it to your stroke protocol.
    http://www.sciencemag.org/content/338/6112/1303.short


    The overarching strategy of all immune systems is as predictable as the plot of an episode of Mission: Impossible. A short-lived message describing the problem reaches commanding immune cells. A team of specialized expert cells is then dispatched to deal with the problem. Once successfully addressed, the team disappears without leaving a trace. On page 1353 of this issue, Kyritsis et al. (1) characterize an astonishing type of immune response—a new team of “executioner” cells—that is implemented when the zebrafish brain is injured. By tricking the immune system into believing neuronal injury had occurred, the authors discovered that inflammation alone is sufficient to switch on neurogenesis. The molecular components used by the highly specialized immune cells that promote neurogenesis represent potential novel therapeutic targets that could promote brain repair.

    Tuesday, November 20, 2012

    Regenerative Neurogenesis from Neural Progenitor Cells Requires Injury-Induced Expression of Gata3

    If zebrafish can regenerate neurons after injury study away.
    http://www.sciencedirect.com/science/article/pii/S1534580712004777

    Summary

    The adult zebrafish brain, unlike mammalian counterparts, can regenerate after injury owing to the neurogenic capacity of stem cells with radial glial character. We hypothesized that injury-induced regenerative programs might be turned on after injury in zebrafish brain and enable regenerative neurogenesis. Here we identify one such gene—the transcription factor gata3—which is expressed only after injury in different zebrafish organs. Gata3 is required for reactive proliferation of radial glia cells, subsequent regenerative neurogenesis, and migration of the newborn neurons. We found that these regeneration-specific roles of Gata3 are dependent on the injury because Gata3 overexpression in the unlesioned adult zebrafish brain is not sufficient to induce neurogenesis. Thus, gata3 acts as a specific injury-induced proregenerative factor that is essential for the regenerative capacity in vertebrates.

    Saturday, February 4, 2012

    Wednesday, January 25, 2012

    Animal Models of Angiogenesis and Lymphangiogenesis

    A good explanation of what would need to occur in the brain for our purposes.
    http://www.intechopen.com/source/pdfs/26387/InTech-Animal_models_of_angiogenesis_and_lymphangiogenesis.pdf
    1. Introduction
    Blood and lymphatic vessels are present in all tissues, and play important roles for their function, homeostasis and maintenance. Angiogenesis, the growth of new blood vessels, is therefore highly important during development, but is largely not observed in the adult, except for during the female reproduction cycle and during wound healing. In pathological situations, however, angiogenesis may be turned on, and in this case contribute to the onset and progression of most severe human pathologies characterized by high mortality, including cancer, diabetes, obesity and retinopathies (Carmeliet, 2003) or is insufficiently activated such as in the case of myocardial infarction and stroke (Y Cao et al, 2005). Thus, angiogenesis is one of the largest and fastest evolving areas of research today. Angiogenesis is a highly complicated process, involving many different cell types, and it is therefore highly recommended that researchers use in vivo animal models for their studies.
    Accordingly, today there are many in vivo models available.
    The aim of this chapter is to give insights into the most commonly used in vivo angiogenesis models in both mice and zebrafish. We will provide detailed descriptions and discussions of the adipose tissue-, tumor-, ischemic hind limb- wound healing- and corneal micropocket angiogenesis models in mice and developmental-, tumor-, hypoxia-induced retinal- and regenerating tail fin angiogenesis models in zebrafish. We will provide a base for comparison between the different assays to quickly identify which model is best suited for a particular research focus.
    1.1 Basic mechanisms of angiogenesis
    Angiogenesis is a multistep process which is tightly regulated by an intimate balance between pro- and anti-angiogenic factors. Angiogenesis is stimulated by angiogenic factors the most commonly studied being members of the vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), transforming growth factor (TGF) or platelet derived growth factor (PDGF) families in the tissue.

    Monday, December 26, 2011

    Improved Understanding Of The Thalamus Offers Potential Stroke Therapy

    At least these researchers are thinking about how to help recovery.
    http://www.medicalnewstoday.com/releases/239237.php
    The thalamus is the central translator in the brain: Specialized nerve cells (neurons) receive information from the sensory organs, process it, and transmit it deep into the brain. Researchers from the Institute of Toxicology and Genetics (ITG) of KIT have now identified the genetic factors Lhx2 and Lhx9 responsible for the development of these neurons. Their results contribute to understanding the development of the thalamus. In the long term, they are to help healing thalamic strokes.

    With 100 billion nerve cells, the brain is the most complex organ in the human body. "We want to understand the development program behind," says Dr. Steffen Scholpp from the ITG. "We want to find out how individual parts of the brain develop, this means, what makes precursor cells build a specialized area such as the thalamus." Scholpp's group at ITG studies the development of the thalamus. "It is the central interface between the brain and the outer world: Everything that is perceived via eyes, ears or the tactile sense has to pass the thalamus before it is routed to the cerebral cortex for further processing."

    In the long term, the scientists want to be able to heal damaged brain parts by a tissue replacement therapy. If, for example, brain tissue is damaged after an infarct, the body is not able to regenerate this tissue. "Today, stroke is the most frequent cause of disability acquired at adult age and due to its central role, damage of the thalamus is very serious," emphasizes Steffen Scholpp. "For this reason, we have to find a strategy to activate stem cells such that the damaged tissue can be replaced." Recently, an important step was made by the scientists: By studying zebrafish, they identified Lhx2 and Lhx9, the factors controlling the development of neurons in the thalamus. "Without these factors, the thalamus would accommodate undifferentiated nerve cells only - this means, the precursory cells lack the information required for specialization," explains the biologist. Analysis of brain development in zebrafish allows conclusions to be drawn with respect to the development in all vertebrates, including human. The results of the group are published in the current issue of the PLoS Biology journal.

    In the same study, Scholpp and his team identified another factor that acts as "adhesive" in the thalamus: The cell adhesion molecule Pcdh10b ensures development of the thalamus without mixing with the surrounding brain areas. If this factor is lacking, the neurons differentiate, but do not find their target destination. It is now the objective of the researchers to activate these factors in the cultivating dish (in vitro) in undifferentiated cells first for new thalamus tissue to form. In close cooperation with engineers, the biologists are already developing 2-dimensional cell culture systems. In January, they will start a 3D cell cultivation project. "KIT offers excellent opportunities: Parallel to our research, materials researchers work on the development of various biomaterials (biopolymers) which will be tested in the cultivation experiments", says Scholpp.

    Dr. Steffen Scholpp thinks that it will be possible to heal stroke patients in the future. "Of course, this will take some years. But it is our ultimate goal to take out quiescent stem cells from a stroke patient and to switch on the specific development biology program in these cells outside of the body. Finally, we plan to bring them back to the position of the damaged tissue. This would be real healing."

    Friday, December 2, 2011

    Genome-Wide Study Into New Gene Functions In The Formation Of Platelets

    Needed research into how platelets clump or not clump. Tell your researcher to follow this.
    http://www.medicalnewstoday.com/releases/238511.php
    In a study into the genetics of blood cell formation, researchers have identified 68 regions of the genome that affect the size and number of platelets. Platelets are small cells that circulate in the blood and are key to the processes of blood clotting and wound healing.

    In this genome-wide study, the team used a multidisciplinary approach to successfully identify new genetic variants involved in the formation of platelets and more importantly, defined the function of genes near these variants using a series of biological analyses.

    Abnormally high or low platelet counts can lead to disease. An increase in the number of platelets, or an increase in their size can lead to an increased risk for thrombotic events, like heart attacks and strokes. A very low number of platelets or platelets that do not function well, increases the risk of bleeding.

    "This is a detective story starting with the initial genetic discovery, allowing us to identify new genes that could contribute to platelet associated diseases," says Professor Willem H Ouwehand, senior co-author at the University of Cambridge and NHS Blood and Transplant. "Our aim of this genome-wide meta-analysis study was to discover which genes control the size and number of platelets, to understand how these genes instruct blood stem cells to orchestrate every day the formation of billions of platelets and finally to investigate whether genes associated with heart attacks and strokes overlap with the genes that affect platelet formation."

    In this collaborative study, the team first developed a prioritisation strategy that allowed them to identify and pinpoint the genes underlying the formation of platelets through biological annotations of these genes. This effort laid the foundation for the construction of a protein-protein interaction network that shows how the different genetic players interact. Finally, they analysed the role of the genes in model organisms and found their function to be conserved in evolution.

    The researchers found the newly identified genes associated with platelet characteristics overlap with other genes implicated in inherited bleeding disorders. This genetic overlap suggests that this study may help discover new genes implicated in severe forms of bleeding disorders, providing evidence that the new findings will be significant in clinical research for improvements in the care of patients.

    This study involved about 68,000 individuals from different ancestries (European, South & East Asian) making it the largest genome-wide meta-analysis study to be conducted globally on platelet number and volume.

    "This is the largest dataset of this type ever produced, and yields a wealth of new exciting biological discoveries and insights into the genetic control of blood cell formation," says Dr Nicole Soranzo, senior co-author from the Wellcome Trust Sanger Institute. "Our findings will be relevant not only to better understand the mechanisms leading to the formation of blood cells, but also to pinpoint new genes involved in diseases with altered blood clotting."

    The team examined the role of the genes they identified in the fruit fly and zebrafish. They found that reducing the activity of one of these genes, arhgef3, in fish abrogates not only the production of platelets but also of red blood cells because the blood forming cells cannot capture iron. The study has shown that the human equivalent, ARHGEF3 gene is an important new regulator of the uptake of iron from the diet.

    Tropomyosin 1 is a member of a family of genes already known to be involved in the regulation of muscle contraction and plays a role in an inherited form of heart disease. This study found a novel role for this well-known protein in platelet formation.

    "This study provides a paradigm for how to successfully translate genome-wide association studies into function" says Dr Christian Gieger, senior co-author from the Institute of Genetic Epidemiology at the Helmholtz Center Munich. "We have shown that biologic and functional annotation can greatly enhance our ability to interpret genetic data."

    "These genes could be used in the future as new targets to develop better and safer platelet inhibitors for treatments of patients with heart attacks or strokes."
    Link